A Phase 2, randomized, double-masked, placebo-controlled, parallel-assignment study of topical N-Chlorotaurine (NCT) formulated with ammonium chloride administered for 10 days in patients with epidemic adenoviral keratoconjunctivitis (EKC)

Trial Profile

A Phase 2, randomized, double-masked, placebo-controlled, parallel-assignment study of topical N-Chlorotaurine (NCT) formulated with ammonium chloride administered for 10 days in patients with epidemic adenoviral keratoconjunctivitis (EKC)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Feb 2013

At a glance

  • Drugs Ammonium chloride (Primary) ; N-chlorotaurine (Primary)
  • Indications Adenovirus infections; Infectious keratoconjunctivitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top